LH 05 - Link Heealth Group
Alternative Names: LH-05Latest Information Update: 28 Mar 2020
Price :
$50 *
At a glance
- Originator Link Health Group
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for preclinical development in Mycoses in China
- 01 Jan 2016 Preclinical trials in Mycoses in China (unspecified route) (Link Health Group pipeline, August 2018)
- 01 Jan 2016 Link Health Group submits IND application for Fungal infections in China (Link Health Group pipeline, August 2018)